| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.428 | 0.004 | 0.428 | Phosphodiesterase 5A inhibitor | 0.366 0.004 DBMET03270 0.203 0.005 DBMET03271 | ||
| 0.409 | 0.004 | 0.409 | Phosphodiesterase V inhibitor | 0.349 0.004 DBMET03270 0.192 0.006 DBMET03271 | ||
| 0.447 | 0.044 | 0.601 | Toll-Like receptor agonist | 0.502 0.031 DBMET03270 0.601 0.017 DBMET03271 | DBMET03271 | |
| 0.443 | 0.045 | 0.541 | Toll-Like receptor 7 agonist | 0.499 0.032 DBMET03270 0.541 0.025 DBMET03271 | DBMET03271 | |
| 0.245 | 0.008 | 0.245 | MAP kinase kinase 5 inhibitor | 0.229 0.012 DBMET03270 0.204 0.029 DBMET03271 | ||
| 0.231 | 0.026 | 0.243 | Phosphodiesterase inhibitor | 0.243 0.024 DBMET03270 | DBMET03270 | |
| 0.17 | 0.037 | 0.17 | Nav1.3 sodium channel blocker | |||
| 0.151 | 0.022 | 0.263 | Transcription factor STAT6 inhibitor | 0.133 0.041 DBMET03270 0.263 0.004 DBMET03271 | DBMET03271 | |
| 0.168 | 0.046 | 0.168 | Sodium channel blocker | 0.144 0.062 DBMET03270 | ||
| 0.154 | 0.051 | 0.154 | Sodium channel (voltage-gated) blocker | 0.141 0.061 DBMET03270 | ||
| 0.212 | 0.121 | 0.368 | Transcription factor STAT inhibitor | 0.368 0.028 DBMET03271 | DBMET03271 | |
| 0.221 | 0.15 | 0.221 | Ca(v)3.3 blocker | |||
| 0.072 | 0.009 | 0.072 | CC chemokine 4 receptor antagonist | |||
| 0.116 | 0.062 | 0.196 | Cyclin-dependent kinase 5 inhibitor | 0.099 0.076 DBMET03270 0.196 0.023 DBMET03271 | DBMET03271 | |
| 0.112 | 0.061 | 0.112 | Nav1.4 sodium channel blocker | 0.105 0.068 DBMET03270 | ||
| 0.224 | 0.182 | 0.224 | Antiobesity | 0.205 0.203 DBMET03270 | ||
| 0.123 | 0.081 | 0.238 | Interleukin 4 antagonist | 0.13 0.072 DBMET03270 0.238 0.015 DBMET03271 | DBMET03271 | |
| 0.08 | 0.039 | 0.215 | CDK2/cyclin E2 inhibitor | 0.07 0.048 DBMET03270 0.215 0.008 DBMET03271 | DBMET03271 | |
| 0.089 | 0.053 | 0.11 | Phosphodiesterase IV inhibitor | 0.11 0.038 DBMET03270 | DBMET03270 | |
| 0.077 | 0.043 | 0.077 | Potassium channel (Tandem pore domain) blocker | |||
| 0.246 | 0.217 | 0.283 | Cyclophilin D inhibitor | 0.283 0.178 DBMET03270 | DBMET03270 | |
| 0.076 | 0.05 | 0.076 | Janus tyrosine kinase 2 inhibitor | |||
| 0.06 | 0.039 | 0.06 | Janus tyrosine kinase 1 inhibitor | |||
| 0.023 | 0.006 | 0.023 | Complement factor D inhibitor | |||
| 0.049 | 0.034 | 0.049 | Purinergic P2X antagonist | |||
| 0.058 | 0.044 | 0.058 | CXC chemokine 4 receptor antagonist | 0.055 0.046 DBMET03271 | ||
| 0.064 | 0.052 | 0.064 | Nav1.7 sodium channel blocker | |||
| 0.119 | 0.109 | 0.119 | Tyrosine kinase inhibitor | |||
| 0.062 | 0.053 | 0.062 | Orexin receptor antagonist | |||
| 0.125 | 0.121 | 0.194 | MAP kinase 3 inhibitor | 0.194 0.026 DBMET03271 | DBMET03271 | |
| 0.048 | 0.05 | 0.1 | Cyclin E inhibitor | 0.1 0.024 DBMET03271 | DBMET03271 | |
| 0.04 | 0.044 | 0.093 | Cyclin E1 inhibitor | 0.093 0.021 DBMET03271 | DBMET03271 | |
| 0.08 | 0.085 | 0.101 | Cyclin-dependent kinase 1 inhibitor | 0.101 0.065 DBMET03271 | DBMET03271 | |
| 0.027 | 0.04 | 0.033 | Purinergic P2X3 antagonist | 0.033 0.025 DBMET03271 | DBMET03271 | |
| 0.231 | 0.259 | 0.495 | MAP kinase 1 inhibitor | 0.495 0.055 DBMET03271 | DBMET03271 | |
| 0.012 | 0.054 | 0.021 | Integrin alphaVbeta3 antagonist | 0.021 0.016 DBMET03271 | DBMET03271 | |
| 0.07 | 0.114 | 0.092 | Hematopoietic | 0.092 0.047 DBMET03271 | DBMET03271 | |
| 0.053 | 0.097 | 0.062 | Prolactin release inhibitor | 0.062 0.043 DBMET03270 | DBMET03270 | |
| 0.047 | 0.1 | 0.075 | CXC chemokine receptor antagonist | 0.075 0.043 DBMET03271 | DBMET03271 | |
| 0.078 | 0.131 | 0.189 | Folate antagonist | 0.189 0.012 DBMET03271 | DBMET03271 | |
| 0.1 | 0.159 | 0.13 | Aurora-C kinase inhibitor | 0.13 0.083 DBMET03271 | DBMET03271 | |
| 0.069 | 0.139 | 0.129 | Cyclin-dependent kinase inhibitor | 0.129 0.068 DBMET03271 | DBMET03271 | |
| 0.073 | 0.146 | 0.229 | Cyclin-dependent kinase 7 inhibitor | 0.229 0.025 DBMET03271 | DBMET03271 | |
| 0.062 | 0.144 | 0.091 | Cyclin-dependent kinase 2 inhibitor | 0.091 0.081 DBMET03271 | DBMET03271 | |
| 0.02 | 0.11 | 0.066 | CDK2/cyclin E inhibitor | 0.066 0.037 DBMET03271 | DBMET03271 | |
| 0.026 | 0.122 | 0.132 | Purinergic P2X2 antagonist | 0.132 0.016 DBMET03271 | DBMET03271 | |
| 0.027 | 0.122 | 0.083 | CDK1/cyclin B inhibitor | 0.083 0.032 DBMET03271 | DBMET03271 | |
| 0.07 | 0.176 | 0.128 | Thrombolytic | 0.128 0.101 DBMET03271 | DBMET03271 | |
| 0.076 | 0.197 | 0.117 | Anticoagulant | 0.117 0.116 DBMET03271 | DBMET03271 | |
| 0.049 | 0.172 | 0.086 | Aminoacyl-tRNA synthetase inhibitor | 0.086 0.065 DBMET03271 | DBMET03271 | |
| 0.038 | 0.162 | 0.101 | CDK/cyclin complex inhibitor | 0.101 0.051 DBMET03271 | DBMET03271 | |
| 0.031 | 0.158 | 0.079 | CDK1/cyclin B1 inhibitor | 0.079 0.04 DBMET03271 | DBMET03271 | |
| 0.136 | 0.264 | 0.389 | Immunomodulator | 0.389 0.047 DBMET03271 | DBMET03271 | |
| 0.021 | 0.173 | 0.048 | CDK7/cyclin H inhibitor | 0.048 0.027 DBMET03271 | DBMET03271 | |
| 0.018 | 0.182 | 0.062 | CDK9/cyclin T1 inhibitor | 0.062 0.038 DBMET03271 | DBMET03271 | |
| 0.037 | 0.211 | 0.1 | CDK2/cyclin A inhibitor | 0.1 0.058 DBMET03271 | DBMET03271 | |
| 0.035 | 0.209 | 0.104 | I kappa B kinase 1 inhibitor | 0.104 0.021 DBMET03271 | DBMET03271 | |
| 0.1 | 0.296 | 0.191 | Growth factor agonist | 0.191 0.073 DBMET03271 | DBMET03271 | |
| 0.101 | 0.303 | 0.144 | Cyclin-dependent kinase 3 inhibitor | 0.144 0.112 DBMET03271 | DBMET03271 | |
| 0.024 | 0.236 | 0.099 | Cyclin H inhibitor | 0.099 0.008 DBMET03271 | DBMET03271 | |
| 0.057 | 0.275 | 0.143 | CDK3/cyclin E inhibitor | 0.143 0.032 DBMET03271 | DBMET03271 | |
| 0.04 | 0.281 | 0.323 | CDC-like kinase 2 inhibitor | 0.323 0.026 DBMET03271 | DBMET03271 | |
| 0.043 | 0.3 | 0.289 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.289 0.018 DBMET03271 | DBMET03271 | |
| 0.038 | 0.302 | 0.253 | Clk dual-specificity kinase inhibitor | 0.253 0.054 DBMET03271 | DBMET03271 | |
| 0.039 | 0.308 | 0.241 | CDC-like kinase 4 inhibitor | 0.241 0.049 DBMET03271 | DBMET03271 | |
| 0.085 | 0.369 | 0.247 | Angiogenesis inhibitor | 0.247 0.125 DBMET03271 | DBMET03271 | |
| 0.03 | 0.345 | 0.249 | CDC-like kinase 1 inhibitor | 0.249 0.018 DBMET03271 | DBMET03271 | |
| 0.044 | 0.361 | 0.168 | CDC-like kinase 3 inhibitor | 0.168 0.013 DBMET03271 | DBMET03271 | |
| 0.009 | 0.335 | 0.055 | Cyclin B inhibitor | 0.055 0.039 DBMET03271 | DBMET03271 | |
| 0.032 | 0.374 | 0.116 | Protein kinase (CK1) gamma 1 inhibitor | 0.116 0.103 DBMET03271 | DBMET03271 | |
| 0.029 | 0.387 | 0.285 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.285 0.054 DBMET03271 | DBMET03271 | |
| 0.016 | 0.383 | 0.06 | Cyclin B3 inhibitor | 0.06 0.057 DBMET03271 | DBMET03271 | |
| 0.028 | 0.398 | 0.278 | Dyrk kinase inhibitor | 0.278 0.06 DBMET03271 | DBMET03271 | |
| 0.01 | 0.38 | 0.058 | Cyclin B1 inhibitor | 0.058 0.046 DBMET03271 | DBMET03271 | |
| 0.008 | 0.405 | 0.051 | Cyclin B2 inhibitor | 0.051 0.046 DBMET03271 | DBMET03271 | |
| 0.021 | 0.47 | 0.255 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.255 0.043 DBMET03271 | DBMET03271 | |
| 0.02 | 0.476 | 0.148 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.148 0.015 DBMET03271 | DBMET03271 | |
| 0.067 | 0.528 | 0.158 | Catenin beta inhibitor | 0.158 0.089 DBMET03271 | DBMET03271 | |
| 0.006 | 0.469 | 0.043 | Dihydrofolate reductase inhibitor | 0.043 0.032 DBMET03271 | DBMET03271 | |
| 0.029 | 0.503 | 0.137 | Cytokine production inhibitor | 0.137 0.073 DBMET03271 | DBMET03271 | |
| 0.08 | 0.599 | 0.176 | Peptidyltransferase inhibitor | 0.176 0.135 DBMET03271 | DBMET03271 | |
| 0.022 | 0.568 | 0.168 | Interleukin antagonist | 0.168 0.105 DBMET03271 | DBMET03271 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |